foxo4-dri senolytic Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI - Peptide for Cellular
Description
As FOXO proteins constitute key components of the insulin signaling pathway, the impact of drugs regulating its action significantly influences blood sugar levels [115]
The Journal of Clinical Endocrinology & Metabolism , 70 (4), 975982
The peptide still helps because GHK-CU is remarkably effective even when suboptimally dosed
It does not create a branded finished drug, it does not trigger insurance coverage, and it does not retroactively validate marketing claims made about the compound
It can masquerade as another sickness or deficiency (source)
